Advanced Search

U.S. State Department Releases 2022 Human Rights Reports

03.21.23 (PRESS STATEMENT)  – Yesterday, the U.S. Department of State released the 2022 Country Reports on Human Rights Practices (Human Rights Reports), which includes reporting on the status of sexual and reproductive health and rights [...]

SRHR General,United States,Engaging Policymakers, In Washington D.C.,News

Federal Bill Ensuring Medicaid Coverage for Abortion Introduced in U.S. House

01.26.23 (PRESS STATEMENT) – Today, the EACH Act was introduced in the U.S. House of Representatives by Representatives Barbara Lee, Diana DeGette, Jan Schakowsky, and Ayanna Pressley. This bill would guarantee that people using Medicaid [...]

Abortion,United States,Engaging Policymakers, In Washington D.C.,News

EACH Act Would Remove Bans on Abortion Coverage for Federal Health Programs

Introduced today in the U.S. House of Representatives, the Equal Access to Abortion Coverage in Health Insurance (EACH) Act aims to reduce economic barriers to abortion access.

Abortion, Legal Protections,United States,Engaging Policymakers, In Washington D.C., U.S. Congressional Advocacy,Story

U.S. House Holds Vote to Protect Abortion Nationwide 

01.09.2023 – (PRESS STATEMENT) Tonight, House Democrats attempted to bring the Women’s Health Protection Act (WHPA) for a vote as their first official action of the 118th Congress. However, they did not receive enough votes [...]

Abortion,United States,Engaging Policymakers, In Washington D.C.,News

FDA Action Will Expand Access to Medication Abortion

FDA permanently removes in-person dispensing requirement for mifepristone and allows retail and online pharmacies to directly provide medication to patients.

Abortion, Legal Protections,United States,Engaging Policymakers, In Washington D.C., U.S. Administrative Advocacy,Story
Women’s Health Protection Act (WHPA) card link

Women’s Health Protection Act (WHPA)

WHPA is U.S. federal legislation to protect the right to access abortion care nationwide.

Abortion,United States,Engaging Policymakers, In Washington D.C., U.S. Congressional Advocacy,Resources

FDA Takes Steps to Expand Access to Medication Abortion

01.03.2023 (PRESS RELEASE) – Today, the Food and Drug Administration (FDA) announced that mifepristone—one of two medications used in medication abortion—may now be dispensed directly to patients at pharmacies and through mail order pharmacies with [...]

Abortion,United States,Engaging Policymakers, In Washington D.C.,News

La FDA toma medidas para ampliar el acceso al aborto con medicamentos

La autoridad de regulación de medicamentos en Estados Unidos permitirá de forma permanente el acceso al aborto con píldoras en farmacias y por correo

Abortion,United States,Engaging Policymakers, In Washington D.C.,News

Reproductive rights are human rights.

Help us ensure that every government around the world guarantees them.

Abortion Rights Measures Win Approval in First Major U.S. Elections Since Roe v. Wade Overturned card link

Abortion Rights Measures Win Approval in First Major U.S. Elections Since Roe v. Wade Overturned

Ballot initiatives and elections will shape the direction of abortion access across the U.S.

Abortion, Legal Protections,United States,Engaging Policymakers, In the States (USA), In Washington D.C.,Story

U.S. Defense Department to Aid Servicemembers’ Travel for Abortion Care

Move comes after years of advocacy by the Center and its coalition partners to improve access to reproductive health care for servicemembers and veterans.

Abortion, Funding for Reproductive Healthcare, Public Funding,United States,Engaging Policymakers, In Washington D.C., U.S. Administrative Advocacy,Story

Comment to the Department of Veterans Affairs on Interim Final Rule on Reproductive Health Services

The Center submitted the comment in support of the rule.

Abortion,United States,Engaging Policymakers, In Washington D.C., U.S. Administrative Advocacy,Documents

Center Joins to Petition the FDA to Improve Treatment for Miscarriage Care

Nearly 50 organizations seek to expand access to essential medications for miscarriage care and remove legal risks to providers and patients.

Maternal Health, Access to Quality Care,United States,Engaging Policymakers, In Washington D.C., U.S. Administrative Advocacy,Story

Citizen Petition to the FDA on the Use of Mifepristone for Miscarriage Management

The Center was one of 49 leading medical and scientific associations, research institutions, and advocacy organizations joining to submit this petition to the FDA on October 4, 2022. It requests that miscarriage management be added [...]

Maternal Health,United States,Engaging Policymakers, In Washington D.C., U.S. Administrative Advocacy,Documents

Reproductive rights are human rights.

Help us ensure that every government around the world guarantees them.